SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-036704
Filing Date
2024-02-14
Accepted
2024-02-14 19:03:59
Documents
3
Group Members
CLAUDIO NESSIOMEGA FUND VII GP MANAGER, LTD.OMEGA FUND VII GP, L.P.OTELLO STAMPACCHIA

Document Format Files

Seq Description Document Type Size
1 SC 13G d781085dsc13g.htm SC 13G 107379
2 EX-99.1 d781085dex991.htm EX-99.1 6448
3 EX-99.2 d781085dex992.htm EX-99.2 10178
  Complete submission text file 0001193125-24-036704.txt   125743
Mailing Address 888 BOYLSTON STREET SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON STREET SUITE 1111 BOSTON MA 02199 857-268-4422
Omega Fund VII, L.P. (Filed by) CIK: 0001856879 (see all company filings)

IRS No.: 981592224 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Subject) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: SC 13G | Act: 34 | File No.: 005-94211 | Film No.: 24641399
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)